Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

A Story of Significant EF Improvement with Biventricular Impella® Support

To the surprise of all the treating cardiologists, the patient presented with an ejection fraction of 5%, which improved to 55% on Day 6 after support with Impella RP® and Impella CP®.

Dhruva et al. 

This FAQ explains how the conclusions of Dhruva et al. conflict with Impella® best practice outcomes reported in more robust, previously published, contemporary, prospective studies.

Information for Physicians: Medical Office Review of Dhruva et al.

Seth Bilazarian, MD, identifies and discusses a number of limitations of the Dhurva et al. paper.

FAQ: Is There Randomized Controlled Trial Data Available for Impella® Heart Pump Use in Cardiogenic Shock?

This FAQ discusses the challenges of obtaining RCT data for cardiogenic shock and presents the clinical data that is currently available and ongoing.

Discover New Data on Protected PCI versus Bailout PCI

Alexander Truesdell, MD, discusses Protected PCI versus bailout PCI using data from the cVAD Study and the PROTECT III study. 

NCSI Study: About 40% of AMICS Patients Develop Right Ventricular Dysfunction

Babar Basir, DO, discusses NCSI study findings on right ventricular dysfunction in AMI cardiogenic shock.

Looking to Clinical Evidence in Cardiogenic Shock

William O’Neill, MD discusses cardiogenic shock treatment in light of the lack of randomized, controlled clinical trial data for cardiogenic shock.

Door-to-Unload (DTU) in STEMI Trial Summary: Pilot Trial and Pivotal Trial Design

Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.

Impella RP® Support for Univentricular Shock

Navin Kapur, MD, uses Impella RP to effectively manage univentricular shock in a patient with right ventricular failure.

Alternative Access Sites for Large Bore Procedures with Rajiv Tayal, MD

Rajiv Tayal, MD, discusses axillary access techniques for large bore procedures as well as other alternative access skills for advanced interventional operators.

What is the STEMI DTU™ Pivotal Trial?  

The STEMI DTU pivotal trial is a prospective, multicenter, two-arm randomized controlled trial that plans to enroll 668 patients undergoing treatment for a STEMI heart attack. 

Instituting a Cardiogenic Shock Protocol to Improve Outcomes

Alexander Truesdell, MD, and Behnam Tehrani, MD, discuss improved outcomes after implementing a cardiogenic shock protocol at Inova Heart and Vascular Institute. 

Data from the NCSI Study Demonstrates 72% Survival with 98% Native Heart Recovery

William O'Neill, MD, discusses data from the National Cardiogenic Shock Initiative (NCSI) study presented at the 2019 SCAI Scientific Sessions.

Discussion of a Retrospective Matched-Pair Analysis Comparing Patients in Cardiogenic Shock Treated with Balloon Pump and the Impella® Heart Pump

Seth Bilazarian, MD, discusses the limitations of Schrage, Ibrahim, et al. published in Circulation comparing patients in cardiogenic shock treated with balloon pump and the Impella® heart pump. 

What is NCSI Study?

The NCSI Study is based on adopting the best practices algorithm focused on identifying shock early and unloading using Impella devices before PCI, reducing use of inotropes, and the use of invasive hemodynamic monitoring to aid in escalation and weaning.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].